TABLE 2.
S. aureus strains used in this study
| Straina | Relevant characteristic(s) | Reference or source |
|---|---|---|
| MRSA USA300 strains | ||
| Wild type | AH1263 | 78 |
| fakA mutant | ΔfakA | 62 |
| aur mutant | aur::erm | This study |
| sspA mutant | sspA::erm | This study |
| geh mutant | geh::erm | This study |
| lip mutant | lip::erm | This study |
| geh lip mutant | geh::tet lip::erm | This study |
| AH1263 triclosan-resistant strains | ||
| Trial 1, isolate A (1A) | accB fatty acid auxotroph | This study |
| Trial 1, isolate B (1B) | Fatty acid auxotroph | This study |
| Trial 1, isolate C (1C) | accC fatty acid auxotroph | This study |
| Trial 2, isolate A (2A) | accA fatty acid auxotroph | This study |
| Trial 2, isolate B (2B) | Fatty acid auxotroph | This study |
| Trial 2, isolate C (2C) | accD fatty acid auxotroph | This study |
| Trial 3, isolate A (3A) | Fatty acid auxotroph | This study |
| Trial 3, isolate B (3B) | Fatty acid auxotroph | This study |
| Trial 3, isolate C (3C) | fadD accC fatty acid auxotroph | This study |
| MSSA NM strains | ||
| Wild type | Lipase negative | 79 |
| TB4 | Prophage repaired, lipase positive | 60 |
| TB4 geh mutant | geh::erm | This study |
| Cystic fibrosis isolates | ||
| CF:716 | Lipase positive | This study |
| CF:720 | Lipase negative | This study |
| CF:769 | Lipase negative | This study |
| CF:781 | Lipase negative | This study |
| CF:789 | Lipase positive | This study |
| CF:796 | Lipase positive | This study |
a
MRSA, methicillin-resistant S. aureus; MSSA, methicillin-sensitive S. aureus.